SSL tight-lipped over possible medical sale to VC (venture capital) firm
This article was originally published in Clinica
SSL International has refused to comment on reports that venture capital firm 3i has outbid rivals Morgan Stanley Capital Partners and Apax Partners in a contest for a part of the UK firm's medical division. Sources close to the negotiations have confirmed the names of the final three bidders and 3i told Clinica it was "in active discussions with the company". Rumour has it that the surgical glove and antiseptics business could be sold for as much as £250-275m ($425-470m).